Join Now My Chatterbean
 
Home > Articles > Health > Senior & Caregiving > Blood & Pressure > FDA Approves Tekturna HCT(R) as Initial Treatment in Patients Unlikely to Achieve Their Blood Pressure Goals With a Single Agent
health

FDA Approves Tekturna HCT(R) As Initial Treatment In Patients Unlikely To Achieve Their Blood Pressure Goals With A Single Agent

Featured on: Biotech Finances
Publication date: Jul 21, 2009
Tekturna HCT (aliskiren and hydrochlorothiazide)--an initial treatment for high blood pressure sufferers requiring multiple medications to control hypertension--is the latest on the docket of the Food and Drug Administration. The FDA approved the drug, opening it up for further testing and prescription to patients looking to control hypertension.

Read Full Article

More Blood Pressure Articles

Moderate Alcohol Consumption Lowers MI Risk In Hypertensive Men
Remedies For High Blood Pressure ? Take Control Of Your Life | Diseases
High Blood Pressure Drug Could Prevent Dementia
Blood Pressure Pill Exforge HCT Approved
Overweight Male Teenagers With Normal Blood Pressures Showing Signs Of Heart Damage
Grant, Efforts Seek To Address Racial, Ethnic Health Disparities
ACE Inhibitor Subclass May Prevent Dementia In Hypertensive Patients
A Guide To High Blood Pressure Diet
New Drug Promises To Reduce Damage From A Heart Attack
Pivotal Data Demonstrating Efficacy Of Darusentan In Treating Resistant Hypertension Published In The Lancet
Advertisement


 
Not a member? Join now. Membership is free and packed with perks.